Search results
Researchers are working on a new mRNA vaccine—this time for bird flu
Fast Company Magazine· 7 days agoConcerns about bird flu continue to grow as a new deadly subtype spreads among wild animals and...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020 ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 6 days agoLondon-based EyeBio, which operates as Eyebiotech Ltd, has operations in the United States and the...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
Reuters via Yahoo Finance· 6 days ago(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion,...
Antibody discovery promises new hope in influenza B battle, paves way for universal vaccine
Medical Xpress· 3 days agoSeasonal flu vaccines cover influenza B and the more common influenza A but do not stimulate the broadest possible range of immune responses against both viruses. In addition ...
Did pandemic lockdowns stunt kids' immune systems long-term?
Live Science via Yahoo News· 5 days agoCommon illnesses spiked in kids as COVID-related social distancing policies were lifted. But experts...
Opinion: America can raise vaccine rates at home and abroad
Tulsa World· 6 days agoGrowing up in Tulsa, I've been aware of inequities in health care at home, seeing how not all...
Did pandemic lockdowns stunt kids' immune systems long-term?
LiveScience· 5 days agoThe COVID-19 pandemic drastically reduced people's in-person interactions with others as events were...
Medications to Treat Upper Respiratory Infections
Healthline· 6 days agoMedications such as nasal decongestants and cough suppressants may help manage symptoms of upper respiratory infections. A respiratory infection affects...
Study of deadly Australian Japanese encephalitis virus strain prompts push for new vaccine
Medical Xpress· 7 days agoResearchers have conducted the first comprehensive two-year laboratory characterization of the rare sub-type of the mosquito-borne Japanese encephalitis virus (JEV) that caused an unprecedented deadly outbreak in Australia in 2022.